Your browser doesn't support javascript.
loading
High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro.
Soldati, Sasha; Bär, Alexander; Vladymyrov, Mykhailo; Glavin, Dale; McGrath, James L; Gosselet, Fabien; Nishihara, Hideaki; Goelz, Susan; Engelhardt, Britta.
Afiliação
  • Soldati S; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.
  • Bär A; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.
  • Vladymyrov M; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.
  • Glavin D; Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
  • McGrath JL; Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
  • Gosselet F; Blood-Brain Barrier Laboratory, University of Artois, Lens, France.
  • Nishihara H; Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012, Bern, Switzerland.
  • Goelz S; Department of Neurotherapeutics, Yamaguchi University, Yamaguchi, Japan.
  • Engelhardt B; Biogen, Cambridge, MA, USA.
J Neuroinflammation ; 20(1): 123, 2023 May 23.
Article em En | MEDLINE | ID: mdl-37221552
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Barreira Hematoencefálica / Linfócitos T Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Barreira Hematoencefálica / Linfócitos T Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article